Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient

Clinical Infectious Diseases

Volumn 28, Issue 3, 1999, Pages 690-691

  Ribaud, Patricia ^a,b   Scieux, Catherine ^a,b   Freymuth, François ^a,b   Morinet, Frédéric ^a,b   Gluckman, Eliane ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b CHU Clemenceau   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; RIBAVIRIN;

ADENOVIRUS; ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FECES ANALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS INFECTION;

EID: 0033014906     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517222     Document Type: Article

References (4)

1. 1. Flomenberg P, Babbitt J, Drobyski WR, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994;169:775-81.
2. 2. Carrigan D. Adenovirus infections in immunocompromised patients. Am J Med 1997;102:71-4.
3. 3. Hromas R, Clark C, Blanke C, et al. Failure of ribavirin to clear adenovirus infections in T-cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;14:663-4.
4. 4. Hedderwick SA, Greenson JK, McGaughy VR, et al. Adenovirus cholecystitis in a patient with AIDS. Clin Infect Dis 1998;26:997-9.